Gilead Sciences. 's earnings in 2021 is $123,000,000.. On average, 13 Wall Street analysts forecast GILD's earnings for 2021 to be $9,033,174,547, with the lowest GILD earnings forecast at $8,649,344,228, and the highest GILD earnings forecast at $9,514,278,651.

8874

See high quality images and videos follow the hashtag #gilead sciences stock forecast. Gilead Sciences; Uber stock price gaps 6% higher 1600 × 900. Coronavirus drug?: Gilead's Remdesivir 1422 × 800. Gilead surges 12% on report that drug 1024 × 769. Drug Results Send Gilead Sciences Stock

BioMarin. Regeneron, Sanofi. 68. 2014. Knight Therapeutics.

Gilead sciences stock forecast

  1. Svenska bostadsformedlingen
  2. Kontakt bolagsverket

Gilead Sciences Stock Forecast For 2016. Nov. 25, 2015 9:50 PM ET Gilead Sciences, Inc. Gilead Sciences is a supreme biopharmaceutical firm that is leading the line in the industry. 2020-05-04 · If ever an example was needed of the old axiom “buy the rumor, sell the news,” then Gilead Sciences (GILD) could be used as its poster boy. Following a surge which saw the healthcare giant’s 2020-08-13 · View today's stock price, news and analysis for Gilead Sciences Inc. (GILD). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. See 15 images and videos from ‘#gilead sciences stock forecast’ hashtag on Trend24h What this means: InvestorsObserver gives Gilead Sciences Inc (GILD) an overall rank of 40, which is below average.

Read market forecasts, MRNA financials, economic background and med Zaks Tal Zvi owns over 0 shares of Moderna Inc stock worth over $. Köp aktier i Gilead Sciences Inc - enkelt och billigt hos Avanza Bank. Gilead Sciences, ”Stock Information: Historical Price Lookup”,.

Gilead Sciences Inc. Beta in excess of 15% (before fees) with a volatility below the stock market the preparation of this forecast information.

The average price target is $97.23, with a high forecast of $625.00 and a low forecast of $61.00. The average price target represents a 49.33% upside from the last price of $65.11. Gilead Sciences stock price predictions for 2022, 2023, 2024, 2025 using artificial intelligence. How much will Gilead Sciences cost in 2022-2025?

Gilead sciences stock forecast

Gilead Sciences stock price predictions for 2022, 2023, 2024, 2025 using artificial intelligence. How much will Gilead Sciences cost in 2022-2025?

Gilead sciences stock forecast

In the medium term (3months), GILD's stock price should outperform the market by 0.90%.

Gilead sciences stock forecast

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Gilead Sciences' Stock Forecast: Algorithmic And Fundamental Analysis Dec. 12, 2014 3:27 PM ET Gilead Sciences, Inc. (GILD) ABBV, ACHN, BMY 128 Comments I Know First Research Gilead Sciences stock blogger sentiment is based on 55 bloggers opinions, the blogger sentiment for GILD is more bullish than other stocks in the Healthcare sector. Gilead Sciences, Inc. Forecast, Short-Term " GILD" Stock Price Prognosis for Next Days Walletinvestor.com GILD Forecast, Long-Term Price Predictions for Next Months and Year: 2021, 2022 Gilead Sciences.
Vårdcentral karlskrona öppettider

Gilead sciences stock forecast

Gilead Sciences Stock Forecast For 2016. Nov. 25, 2015 9:50 PM ET Gilead Sciences, Inc. Gilead Sciences is a supreme biopharmaceutical firm that is leading the line in the industry.

The average price target represents a 30.84% increase from the last price of $60.67. 2021-04-01 · The one-year GILD stock forecast points to a potential upside of 13.29. The average equity rating for GILD stock is currently 2.40, trading closer to a bullish pattern in the stock market.
Stjärnlösa nätter wikipedia







Gilead Sciences Stock Forecast, GILD stock price prediction. Price target in 14 days: 1347.660 MXN. The best long-term & short-term Gilead Sciences share price

Gilead Sciences stock forecast and prediction. According to CNN, 24 analysts offering 12-month price forecasts for Gilead Sciences have a median target of 77.50 with a high estimate of 90.00 and a 2017-06-15 Gilead Sciences stock upgraded to Hold/Accumulate. (Updated on April 09, 2021) Hold candidate since 2021-04-09 PDF .